JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | -26.3% | 6,400 | 0.0% | 0.00% | – |
| Q2 2022 | $19,000 | -77.4% | 6,400 | -48.4% | 0.00% | – |
| Q1 2022 | $84,000 | -18.4% | 12,400 | 0.0% | 0.00% | – |
| Q4 2021 | $103,000 | +12.0% | 12,400 | 0.0% | 0.00% | – |
| Q3 2021 | $92,000 | -64.8% | 12,400 | -67.7% | 0.00% | -100.0% |
| Q2 2021 | $261,000 | -33.8% | 38,400 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $394,000 | +47.0% | 38,400 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $268,000 | -25.3% | 38,400 | -12.7% | 0.00% | -50.0% |
| Q3 2020 | $359,000 | +18.5% | 44,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $303,000 | +45.0% | 44,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $209,000 | -45.6% | 44,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $384,000 | +163.0% | 44,000 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $146,000 | -60.1% | 44,000 | -40.5% | 0.00% | -50.0% |
| Q2 2019 | $366,000 | -20.1% | 74,000 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $458,000 | +83.9% | 74,000 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $249,000 | -48.2% | 74,000 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $481,000 | -15.0% | 74,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $566,000 | -67.5% | 74,000 | -5.1% | 0.00% | -70.0% |
| Q1 2018 | $1,743,000 | +75.4% | 78,000 | 0.0% | 0.01% | +100.0% |
| Q4 2017 | $994,000 | +106.2% | 78,000 | +151.6% | 0.01% | +66.7% |
| Q3 2017 | $482,000 | – | 31,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |